Ticker: RXRX

Company: RECURSION PHARMACEUTICALS, INC.

Person: Blake Borgeson, director

Transaction date: July 7, 2026

Reporting date: July 9, 2026

Average share price: 3.9625

Sold 40000.0 shares for 158500.0